Goodness Growth Holdings, Inc. (GDNSF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Goodness Growth Holdings, Inc. (GDNSF) with AI Score 64/100 (Hold). Goodness Growth Holdings, Inc. is a physician-led cannabis company operating in the United States. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Goodness Growth Holdings, Inc. (GDNSF) Healthcare & Pipeline Overview
Goodness Growth Holdings, Inc. cultivates and distributes cannabis products through its Green Goods dispensaries and wholesale channels. With a focus on environmentally friendly cultivation and pharmaceutical-grade extracts, the company operates in a rapidly evolving US cannabis market, facing both growth opportunities and regulatory challenges.
Investment Thesis
Goodness Growth Holdings, Inc. presents a speculative investment opportunity within the evolving US cannabis market. The company's focus on physician-led operations and environmentally friendly cultivation could appeal to health-conscious consumers and environmentally focused investors. However, the company's negative P/E ratio of -11.69 and a profit margin of -19.4% indicate financial challenges. Growth catalysts include expansion into new states and increased wholesale distribution. Key risks include regulatory uncertainty, competition from larger cannabis companies, and the need to achieve profitability. The company's beta of 1.42 suggests higher volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates 18 dispensaries across Maryland, Minnesota, New Mexico, and New York as of March 11, 2022.
- Gross Margin of 43.8% indicates potential for profitability if operating expenses are managed effectively.
- Market Cap of $0.06B reflects its small size and potential for high growth or significant risk.
- Cultivates cannabis in environmentally friendly greenhouses, appealing to environmentally conscious consumers.
- Sells products through both its own Green Goods dispensaries and third-party wholesale channels, diversifying revenue streams.
Competitors & Peers
Strengths
- Physician-led approach
- Environmentally friendly cultivation practices
- Established retail dispensary network
- Wholesale distribution channels
Weaknesses
- Negative profit margin
- Limited geographic presence
- Small market capitalization
- Reliance on evolving regulatory landscape
Catalysts
- Upcoming: Potential legalization of cannabis in additional states, expanding market opportunities.
- Ongoing: Expansion of the Green Goods dispensary network.
- Ongoing: Development and launch of new cannabis products and formulations.
- Ongoing: Increasing wholesale distribution agreements with third-party dispensaries.
Risks
- Potential: Regulatory changes and uncertainty in the cannabis industry.
- Ongoing: Competition from larger and more established cannabis companies.
- Ongoing: Fluctuations in cannabis prices and market demand.
- Potential: Difficulty in obtaining financing and capital for expansion.
- Ongoing: Negative profit margin and the need to achieve profitability.
Growth Opportunities
- Expansion into New States: Legalization of cannabis in additional states presents a significant growth opportunity for Goodness Growth. Entering new markets would allow the company to increase its revenue base and expand its brand presence. The timeline for this growth is dependent on the pace of legalization efforts in various states, but represents a substantial long-term opportunity.
- Increased Wholesale Distribution: Expanding its wholesale distribution network to third-party dispensaries can significantly increase Goodness Growth's revenue. By partnering with more dispensaries, the company can reach a wider customer base without the capital expenditures associated with opening new retail locations. This strategy can be implemented relatively quickly, providing near-term revenue growth.
- Development of New Cannabis Products: Investing in research and development to create new and innovative cannabis products can drive growth. This includes developing new strains, formulations, and delivery methods to meet evolving consumer preferences. The timeline for this growth depends on the R&D process, but successful product launches can create a competitive advantage.
- Focus on Medical Cannabis Market: Goodness Growth's physician-led approach positions it well to capitalize on the medical cannabis market. By focusing on developing cannabis-based therapies for specific medical conditions, the company can attract patients seeking alternative treatments. This market segment is expected to grow as more research supports the therapeutic benefits of cannabis.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the cannabis industry or acquiring smaller players can accelerate growth. Partnerships can provide access to new markets, technologies, or distribution channels. Acquisitions can consolidate market share and create synergies. These opportunities can arise at any time, depending on market conditions and company strategy.
Opportunities
- Expansion into new states
- Increased wholesale distribution
- Development of new cannabis products
- Focus on medical cannabis market
Threats
- Regulatory uncertainty
- Competition from larger cannabis companies
- Fluctuations in cannabis prices
- Changes in consumer preferences
Competitive Advantages
- Physician-led approach provides credibility in the medical cannabis market.
- Environmentally friendly cultivation practices appeal to eco-conscious consumers.
- Established network of Green Goods dispensaries provides a direct sales channel.
- Proprietary formulations and extraction processes create product differentiation.
About GDNSF
Goodness Growth Holdings, Inc., formerly known as Vireo Health International Inc., is a physician-led cannabis company established to cultivate, manufacture, and distribute cannabis products in the United States. Founded with a commitment to environmentally sustainable practices, the company operates greenhouses for cannabis cultivation and produces pharmaceutical-grade cannabis extracts. Goodness Growth sells its products through its network of Green Goods retail dispensaries and via wholesale agreements with third-party dispensaries. As of March 11, 2022, the company managed 18 dispensaries across Maryland, Minnesota, New Mexico, and New York. Additionally, the company supplies wholesale cannabis products to third-party companies in Arizona, Maryland, Minnesota, and New York. The company changed its name to Goodness Growth Holdings, Inc. in June 2021, and is headquartered in Minneapolis, Minnesota. The company aims to provide high-quality cannabis products while maintaining environmentally conscious and physician-led operational standards.
What They Do
- Cultivates cannabis in environmentally friendly greenhouses.
- Manufactures pharmaceutical-grade cannabis extracts.
- Operates a network of Green Goods retail dispensaries.
- Sells cannabis products through third-party dispensaries.
- Develops and markets cannabis-based therapies.
- Engages in wholesale distribution of cannabis products.
Business Model
- Cultivation and processing of cannabis.
- Retail sales through company-owned dispensaries.
- Wholesale distribution to third-party retailers.
- Development and sale of cannabis extracts and derivative products.
Industry Context
Goodness Growth Holdings operates within the rapidly expanding US cannabis market, which is characterized by evolving regulations and increasing consumer acceptance. The industry is highly competitive, with companies like BIOGF (BioHarvest Sciences Inc.), BSTG (BioStar Group, Inc.), EEOIF (Empower Clinics Inc.), EOFBY (EnWave Corporation), and HRPMF (Heritage Cannabis Holdings Corp) vying for market share. The trend towards legalization in more states presents significant growth opportunities, but also regulatory hurdles and compliance costs. Companies that can establish strong brands and efficient operations are best positioned to succeed.
Key Customers
- Medical cannabis patients seeking alternative therapies.
- Adult-use cannabis consumers in legalized states.
- Third-party dispensaries purchasing wholesale products.
- Healthcare providers recommending cannabis treatments.
Financials
Chart & Info
Goodness Growth Holdings, Inc. (GDNSF) stock price: Price data unavailable
Latest News
No recent news available for GDNSF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GDNSF.
Price Targets
Wall Street price target analysis for GDNSF.
MoonshotScore
What does this score mean?
The MoonshotScore rates GDNSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Joshua Nathaniel Rosen
CEO
Joshua Nathaniel Rosen serves as the CEO of Goodness Growth Holdings, Inc. His background and specific career history prior to joining Goodness Growth are not detailed in the provided data. As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving growth in the competitive cannabis market. His leadership is crucial for navigating the regulatory complexities and capitalizing on the opportunities within the evolving industry.
Track Record: Due to limited information, Joshua Nathaniel Rosen's specific achievements and strategic decisions at Goodness Growth Holdings, Inc. cannot be fully assessed. However, as CEO, he is responsible for guiding the company's expansion, managing its financial performance, and ensuring compliance with regulations. His success will be measured by the company's ability to achieve profitability and increase market share in the long term.
GDNSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Goodness Growth Holdings, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies on this tier may have limited information available to investors, and trading activity can be sporadic. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other stocks often have less stringent listing requirements, leading to increased risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: The unknown disclosure status increases the risk due to lack of transparency.
- Low Liquidity: The stock may be difficult to buy or sell quickly.
- Price Volatility: OTC stocks are generally more volatile than exchange-listed stocks.
- Regulatory Scrutiny: Cannabis companies face evolving and uncertain regulations.
- Going Concern Risk: Companies on the OTC Other tier may have financial difficulties.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with cannabis regulations.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any legal or regulatory actions against the company.
- Operation of multiple dispensaries in several states.
- Focus on environmentally friendly cultivation practices.
- Physician-led approach to cannabis product development.
- Wholesale distribution agreements with third-party retailers.
GDNSF Healthcare Stock FAQ
What does Goodness Growth Holdings, Inc. do?
Goodness Growth Holdings, Inc. is a physician-led cannabis company that cultivates, manufactures, and distributes cannabis products in the United States. The company operates environmentally friendly greenhouses for cannabis cultivation and produces pharmaceutical-grade extracts. It sells its products through its Green Goods retail dispensaries and via wholesale agreements with third-party dispensaries. The company focuses on providing high-quality cannabis products while adhering to environmentally conscious and physician-led operational standards, serving both medical and adult-use markets.
What do analysts say about GDNSF stock?
AI analysis is currently pending for GDNSF, so there is no available analyst consensus. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and the risks associated with investing in OTC stocks and the cannabis industry. Key valuation metrics to consider include the company's market capitalization, revenue growth, and profitability. The evolving regulatory landscape and competitive dynamics of the cannabis market should also be taken into account.
What are the main risks for GDNSF?
Goodness Growth Holdings, Inc. faces several risks, including regulatory uncertainty in the cannabis industry, competition from larger and more established companies, and fluctuations in cannabis prices and market demand. The company's negative profit margin and the need to achieve profitability also pose significant challenges. As an OTC stock, GDNSF is subject to increased price volatility and liquidity risk. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for GDNSF?
Goodness Growth Holdings, Inc. (GDNSF) currently holds an AI score of 64/100, indicating moderate score. Key strength: Physician-led approach. Primary risk to monitor: Potential: Regulatory changes and uncertainty in the cannabis industry.. This is not financial advice.
How frequently does GDNSF data refresh on this page?
GDNSF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GDNSF's recent stock price performance?
Recent price movement in Goodness Growth Holdings, Inc. (GDNSF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Physician-led approach. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GDNSF overvalued or undervalued right now?
Determining whether Goodness Growth Holdings, Inc. (GDNSF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GDNSF?
Before investing in Goodness Growth Holdings, Inc. (GDNSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's OTC disclosure status.
- AI analysis pending, limiting the availability of analyst insights.